Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contrast-Enhanced Breast MRI For Evaluation Of Patients Undergoing Neoadjuvant Treatment For Locally-Advanced Breast Cancer (I-SPY 1/ACRIN 6657)

NCT00043017 is registered in ClinicalTrials.gov with American College of Radiology Imaging Network as lead sponsor.

NCT NCT00043017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00043017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contrast-Enhanced Breast MRI For Evaluation Of Patients Undergoing Neoadjuvant Treatment For Locally-Advanced Breast Cancer (I-SPY 1/ACRIN 6657)
Lead sponsor
American College of Radiology Imaging Network
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2002
Completion date
March 31, 2011
Enrollment
356 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer